Aurobindo Pharma Limited
Aurobindo Pharma is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.(Source : 202003 Annual Report Page No:159)
What Aurobindo files
- Others79
- Updates76
- Investor Meet65
- Important35
- JV/Acquisition25
- Board Meeting11
Aurobindo Pharma's Board has approved the transfer of its domestic branded generic pharmaceutical formulations business to its wholly-owned subsidiary, Auropharm Limited. **Issue:** Aurobindo Pharma is transferring its domestic branded generic pharma business, a relatively small part of its overall operations, to a subsidiary. * The business contributed about 175.34 Cr...
Government imposed Minimum Import Price (MIP) on Penicillin-G and other pharma ingredients. Aurobindo's subsidiary, Lyfius Pharma, manufactures Penicillin-G, which could benefit from reduced import competition. The company stated recent share volume movement is market-driven, with no new specific info.
Aurobindo Pharma Limited has informed the Exchange regarding 'Clarification on Significant Volume Movement in Company s Shares sought vide letter No..:NSE/CM/Surveillance/16398 dated January 30, 2026.
Aurobindo Pharma clarified that recent share volume movement is market-driven. The company confirmed no undisclosed material information or pending announcements could explain the activity, assuring investors there's no hidden news.
Aurobindo Pharma has announced its 38th Annual General Meeting (AGM) will be held on September 10, 2025, at 3:30 p.m. IST via Video Conferencing. The company will circulate the AGM notice and Annual Report to shareholders. For the purpose of the AGM, the Register of Members and Share Transfer Books...